Yifeng Pharmacy Chain Co., Ltd. (SHA:603939)
China · Delayed Price · Currency is CNY 22.71
-0.02 (-0.09%)
Aug 3, 2026, 3:00 PM CST
Yifeng Pharmacy Chain Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 3,018 | 3,081 | 3,579 | 3,566 | 4,113 | 2,921 |
Short-Term Investments | - | 163.61 | 20.52 | - | - | - |
Trading Asset Securities | 6,336 | 5,854 | 4,407 | 1,631 | 50.05 | 152.19 |
Cash & Short-Term Investments | 9,354 | 9,098 | 8,006 | 5,197 | 4,163 | 3,073 |
Cash Growth | 10.02% | 13.64% | 54.07% | 24.84% | 35.46% | -25.22% |
Accounts Receivable | 1,808 | 1,985 | 2,153 | 2,150 | 1,846 | 1,087 |
Other Receivables | 430.91 | 501.42 | 477.94 | 448.54 | 419.47 | 323.6 |
Receivables | 2,239 | 2,486 | 2,631 | 2,599 | 2,265 | 1,411 |
Inventory | 4,207 | 4,637 | 4,528 | 3,808 | 3,615 | 3,041 |
Prepaid Expenses | - | 30.48 | 37.16 | - | - | 35.17 |
Other Current Assets | 589.18 | 573.74 | 652.9 | 525.62 | 535.91 | 356.71 |
Total Current Assets | 16,388 | 16,826 | 15,856 | 12,129 | 10,578 | 7,916 |
Property, Plant & Equipment | 4,569 | 4,717 | 5,679 | 5,665 | 4,892 | 4,504 |
Long-Term Investments | 134.81 | 133.59 | 530.22 | 592.97 | 334.09 | 6.72 |
Goodwill | 4,766 | 4,765 | 4,769 | 4,611 | 4,188 | 3,718 |
Other Intangible Assets | 470.04 | 480.91 | 483.09 | 470.97 | 478.2 | 389.25 |
Long-Term Deferred Tax Assets | 124.17 | 129.54 | 148.62 | 138.67 | 127.68 | 109.79 |
Long-Term Deferred Charges | 374.23 | 387.72 | 493.88 | 499.14 | 430.69 | 379.59 |
Other Long-Term Assets | 8.77 | 12.25 | 15.17 | 30.27 | 7.23 | 28.39 |
Total Assets | 26,835 | 27,452 | 27,975 | 24,137 | 21,036 | 17,052 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 8,097 | 8,830 | 9,492 | 8,171 | 6,761 | 4,806 |
Accrued Expenses | 326.22 | 632.01 | 587.26 | 549.68 | 683.11 | 390 |
Short-Term Debt | - | - | 30.03 | - | - | - |
Current Portion of Long-Term Debt | 1,081 | 7.46 | 66 | 103.48 | 92.92 | 4.21 |
Current Portion of Leases | - | 1,141 | 1,271 | 1,355 | 1,185 | 931.44 |
Current Income Taxes Payable | 409.73 | 301.88 | 207.1 | 165.76 | 176.87 | 148.83 |
Current Unearned Revenue | 195.31 | 228.52 | 130.07 | 80.17 | 60.69 | 41.1 |
Other Current Liabilities | 547.95 | 612.08 | 814.24 | 844.45 | 700.13 | 424.11 |
Total Current Liabilities | 10,657 | 11,753 | 12,598 | 11,269 | 9,659 | 6,745 |
Long-Term Debt | 1,664 | 1,651 | 1,601 | 133.62 | 228.67 | 365.65 |
Long-Term Leases | 1,531 | 1,605 | 2,313 | 2,206 | 1,951 | 2,024 |
Long-Term Unearned Revenue | 53.08 | 53.19 | 53.63 | 54.09 | 54.69 | 50.34 |
Long-Term Deferred Tax Liabilities | 10.34 | 11.35 | 15.41 | 26.76 | 23.71 | 2.16 |
Total Liabilities | 13,916 | 15,073 | 16,581 | 13,689 | 11,917 | 9,187 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 1,212 | 1,212 | 1,212 | 1,011 | 721.7 | 718.77 |
Additional Paid-In Capital | 3,651 | 3,548 | 3,545 | 3,716 | 3,991 | 3,988 |
Retained Earnings | 7,049 | 6,550 | 5,693 | 4,973 | 3,849 | 2,802 |
Treasury Stock | - | - | -3.76 | -42.24 | -77.41 | -27.76 |
Comprehensive Income & Other | 221.56 | 324.39 | 278.95 | 147.93 | 68.34 | - |
Total Common Equity | 12,134 | 11,634 | 10,726 | 9,804 | 8,553 | 7,481 |
Minority Interest | 785.71 | 744.32 | 667.88 | 642.66 | 565.39 | 383.24 |
Shareholders' Equity | 12,920 | 12,379 | 11,394 | 10,447 | 9,119 | 7,865 |
Total Liabilities & Equity | 26,835 | 27,452 | 27,975 | 24,137 | 21,036 | 17,052 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 4,276 | 4,404 | 5,281 | 3,798 | 3,458 | 3,325 |
Net Cash (Debt) | 5,077 | 4,694 | 2,725 | 1,399 | 705.02 | -252.57 |
Net Cash Growth | 45.82% | 72.25% | 94.78% | 98.44% | - | - |
Net Cash Per Share | 4.11 | 3.80 | 2.21 | 1.16 | 0.58 | -0.21 |
Filing Date Shares Outstanding | 1,212 | 1,212 | 1,212 | 1,213 | 1,212 | 1,208 |
Total Common Shares Outstanding | 1,212 | 1,212 | 1,212 | 1,213 | 1,212 | 1,208 |
Working Capital | 5,731 | 5,073 | 3,258 | 859.44 | 918.95 | 1,171 |
Book Value Per Share | 10.01 | 9.60 | 8.85 | 8.08 | 7.05 | 6.20 |
Tangible Book Value | 6,898 | 6,388 | 5,474 | 4,723 | 3,887 | 3,374 |
Tangible Book Value Per Share | 5.69 | 5.27 | 4.51 | 3.89 | 3.21 | 2.79 |
Buildings | - | 1,598 | 1,364 | 1,291 | 1,004 | 683.76 |
Machinery | - | 1,196 | 1,174 | 1,001 | 843.34 | 722.34 |
Construction In Progress | - | 83.78 | 228.58 | 175.12 | 239.85 | 358.64 |